Hanmi Pharm. Co., Ltd. (KRX:128940)
300,500
-5,500 (-1.80%)
At close: May 28, 2025, 3:30 PM KST
Hanmi Pharm. Revenue
Hanmi Pharm. had revenue of 390.95B KRW in the quarter ending March 31, 2025, a decrease of -3.16%. This brings the company's revenue in the last twelve months to 1.48T, down -3.30% year-over-year. In the year 2024, Hanmi Pharm. had annual revenue of 1.50T with 0.31% growth.
Revenue (ttm)
1,482.77B
Revenue Growth
-3.30%
P/S Ratio
2.66
Revenue / Employee
636.38M
Employees
2,330
Market Cap
3,949.89B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1,495.50B | 4.61B | 0.31% |
Dec 31, 2023 | 1,490.89B | 159.34B | 11.97% |
Dec 31, 2022 | 1,331.55B | 128.36B | 10.67% |
Dec 31, 2021 | 1,203.19B | 127.33B | 11.84% |
Dec 31, 2020 | 1,075.85B | -37.80B | -3.39% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,898.69B |
Celltrion | 3,662.23B |
ALTEOGEN | 151.65B |
Yuhan | 2,114.76B |
SK Biopharmaceuticals | 578.00B |
HLB Co., Ltd. | 74.64B |
Peptron | 3.15B |
PharmaResearch | 392.31B |